Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03560973 |
|---|---|
| Brief Title: | A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM (RAMES) |
| First Submitted : | May 18, 2018 |
| First Submitted that Met QC Criteria : | June 6, 2018 |
| First Posted : | June 19, 2018 |
| Last Update Submitted that Met QC Criteria : | July 29, 2020 |
| Last Update Posted : | July 30, 2020 |